|
Stallcup, William B (2002) The NG2 proteoglycan: past insights and future prospects. J Neurocytol 31:423-35
|
|
Ozerdem, Ugur; Charbono, Wilfred L; Stallcup, William B (2002) Plastic casting of embryonic, placental, and tumor vasculature in the mouse. Microvasc Res 64:486-90
|
|
Ozerdem, Ugur; Monosov, Edward; Stallcup, William B (2002) NG2 proteoglycan expression by pericytes in pathological microvasculature. Microvasc Res 63:129-34
|
|
Ozerdem, U; Grako, K A; Dahlin-Huppe, K et al. (2001) NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 222:218-27
|
|
Stallcup, W B; Dahlin-Huppe, K (2001) Chondroitin sulfate and cytoplasmic domain-dependent membrane targeting of the NG2 proteoglycan promotes retraction fiber formation and cell polarization. J Cell Sci 114:2315-25
|
|
Goretzki, L; Lombardo, C R; Stallcup, W B (2000) Binding of the NG2 proteoglycan to kringle domains modulates the functional properties of angiostatin and plasmin(ogen). J Biol Chem 275:28625-33
|
|
Barritt, D S; Pearn, M T; Zisch, A H et al. (2000) The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2. J Cell Biochem 79:213-24
|
|
Grako, K A; Ochiya, T; Barritt, D et al. (1999) PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse. J Cell Sci 112 ( Pt 6):905-15
|
|
Burg, M A; Pasqualini, R; Arap, W et al. (1999) NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res 59:2869-74
|
|
Fang, X; Burg, M A; Barritt, D et al. (1999) Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. Mol Biol Cell 10:3373-87
|
Showing the most recent 10 out of 31 publications
